GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » EV-to-EBIT

Smruthi Organics (BOM:540686) EV-to-EBIT : 30.85 (As of Jun. 23, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Smruthi Organics's Enterprise Value is ₹1,967 Mil. Smruthi Organics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹64 Mil. Therefore, Smruthi Organics's EV-to-EBIT for today is 30.85.

The historical rank and industry rank for Smruthi Organics's EV-to-EBIT or its related term are showing as below:

BOM:540686' s EV-to-EBIT Range Over the Past 10 Years
Min: -121.41   Med: 10.63   Max: 223.71
Current: 30.85

During the past 13 years, the highest EV-to-EBIT of Smruthi Organics was 223.71. The lowest was -121.41. And the median was 10.63.

BOM:540686's EV-to-EBIT is ranked worse than
75.56% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.05 vs BOM:540686: 30.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Smruthi Organics's Enterprise Value for the quarter that ended in Mar. 2024 was ₹1,783 Mil. Smruthi Organics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹64 Mil. Smruthi Organics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 3.58%.


Smruthi Organics EV-to-EBIT Historical Data

The historical data trend for Smruthi Organics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics EV-to-EBIT Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 10.07 18.15 28.41 27.96

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.41 17.86 27.81 40.71 27.96

Competitive Comparison of Smruthi Organics's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's EV-to-EBIT falls into.



Smruthi Organics EV-to-EBIT Calculation

Smruthi Organics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1967.325/63.78
=30.85

Smruthi Organics's current Enterprise Value is ₹1,967 Mil.
Smruthi Organics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics  (BOM:540686) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Smruthi Organics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=63.78/1783.04143
=3.58 %

Smruthi Organics's Enterprise Value for the quarter that ended in Mar. 2024 was ₹1,783 Mil.
Smruthi Organics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Smruthi Organics (BOM:540686) Business Description

Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines